Author(s): Mayur S. Jain, Shashikant D. Barhate

Email(s): mayurjain176@gmail.com

DOI: Not Available

Address: Mr. Mayur S. Jain*, Dr. Shashikant D. Barhate
Shree Sureshadada Jain Institutes of Pharmaceutical Education and Research, Jammer, Maharashtra (India).
*Corresponding Author

Published In:   Volume - 11,      Issue - 1,     Year - 2021


Cite this article:
Mayur S. Jain, Shashikant D. Barhate. Favipiravir has been investigated for the treatment of life-threatening pathogens such as Ebola virus, Lassa virus, and now COVID-19: A Review. 10.5958/2231-5691.2021.00008.3




Recomonded Articles:

Author(s): Krushna K. Zambare, Avinash B. Thalkari

DOI: 10.5958/2231-5691.2019.00028.5         Access: Open Access Read More

Author(s): Ravi Kumar, Sanjeev Saini, Chatter Singh, Bijander Singh, Alimuddin Saifi

DOI: 10.5958/2231-5691.2020.00022.2         Access: Open Access Read More

Author(s): Rahul D. Shimpi, Shashikant D. Barhate, Mayur S. Jain

DOI: 10.52711/2231-5691.2023.00013         Access: Open Access Read More

Author(s): Manjusha S. Kareppa, Priti B. Savant, Shachi V. Ratnaparkhi, Sohel S. Shaikh, Mohini B. Kadbhane, Someshwar M. Naybal

DOI: 10.52711/2231-5691.2023.00024         Access: Open Access Read More


Recent Articles




Tags